We are live on ! Find out more
SCA

Snowden Capital Advisors Portfolio holdings

AUM $3.76B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+23.4%
3 Year Est. Return
+84.18%
5 Year Est. Return
+103.17%
10 Year Est. Return
+383.86%
AUM
$771M
AUM Growth
+$87.5M
Cap. Flow
+$71.1M
Cap. Flow %
9.22%
Top 10 Hldgs %
16.17%
Holding
451
New
81
Increased
237
Reduced
104
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 13.23%
2 Industrials 6.9%
3 Financials 6.53%
4 Healthcare 6.33%
5 Communication Services 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
401
Air Products & Chemicals
APD
$66.8B
$227K 0.03%
1,456
+27
+2% +$4.42K
ED icon
402
Consolidated Edison
ED
$40.4B
$226K 0.03%
+2,892
New +$221K
FEMB icon
403
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$358M
$225K 0.03%
+5,991
New +$241K
XSLV icon
404
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
$224K 0.03%
+4,646
New +$218K
IWR icon
405
iShares Russell Mid-Cap ETF
IWR
$56.1B
$224K 0.03%
4,232
EVT icon
406
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.09B
$224K 0.03%
9,747
+72
+0.7% +$1.63K
ENB icon
407
Enbridge
ENB
$121B
$223K 0.03%
+6,251
New +$198K
CSQ icon
408
Calamos Strategic Total Return Fund
CSQ
$3.21B
$218K 0.03%
17,234
+544
+3% +$6.7K
FUTY icon
409
Fidelity MSCI Utilities Index ETF
FUTY
$2.33B
$218K 0.03%
6,375
-3,325
-34% -$110K
ETG
410
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.74B
$218K 0.03%
12,801
+142
+1% +$2.42K
AZN icon
411
AstraZeneca
AZN
$266B
$216K 0.03%
3,083
-118
-4% -$8.49K
HTD
412
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$915M
$215K 0.03%
+9,214
New +$206K
LUV icon
413
Southwest Airlines
LUV
$22.3B
$212K 0.03%
4,169
+464
+13% +$24.4K
AME icon
414
Ametek
AME
$55B
$211K 0.03%
+2,924
New +$217K
ETFC
415
DELISTED
E*Trade Financial Corporation
ETFC
$210K 0.03%
+3,441
New +$213K
NOBL icon
416
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$210K 0.03%
+6,750
New +$211K
IDTI
417
DELISTED
Integrated Device Technology I
IDTI
$210K 0.03%
+6,584
New +$209K
OXY icon
418
Occidental Petroleum
OXY
$55.6B
$209K 0.03%
+2,494
New +$199K
FFIV icon
419
F5
FFIV
$22.1B
$208K 0.03%
+1,206
New +$201K
AMT icon
420
American Tower
AMT
$81.3B
$207K 0.03%
+1,433
New +$199K
CPAY icon
421
Corpay
CPAY
$25.5B
$205K 0.03%
+975
New +$200K
FMAT icon
422
Fidelity MSCI Materials Index ETF
FMAT
$589M
$205K 0.03%
6,094
-2,561
-30% -$87.1K
GNTX icon
423
Gentex
GNTX
$5.03B
$203K 0.03%
+8,838
New +$210K
JBLU icon
424
JetBlue
JBLU
$2.29B
$203K 0.03%
10,697
-4,381
-29% -$84.3K
DLS icon
425
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
$200K 0.03%
2,785
+14
+0.5% +$1.07K

Similar funds

Snowden Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Snowden Capital Advisors held 451 positions worth $771M, up 13% from $684M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Snowden Capital Advisors deployed $71.1M of net new capital in Q2 2018, opening 81 new positions and adding to 237 existing holdings. Its largest new stake was Abiomed Inc: 22,880 shares worth $9.36M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares Currency Hedged MSCI EAFE ETF, an estimated $7.54M trimmed.

  • Snowden Capital Advisors's largest Q2 2018 buy was Abiomed Inc: 22,880 shares worth $9.36M.
  • Snowden Capital Advisors added most to iShares International Equity Factor ETF in Q2 2018, an estimated $4.98M increase.
  • Snowden Capital Advisors's biggest Q2 2018 reduction was iShares Currency Hedged MSCI EAFE ETF, cutting an estimated $7.54M.
  • Snowden Capital Advisors fully exited Incyte in Q2 2018, selling an estimated $1.89M.
  • Snowden Capital Advisors's ten largest holdings make up 16% of its $771M portfolio in Q2 2018.
  • Snowden Capital Advisors opened 81 new positions and closed 18 in Q2 2018.
  • Snowden Capital Advisors's portfolio value rose 13% quarter-over-quarter to $771M.

Based on Snowden Capital Advisors's 13F filing for Q2 2018, filed 8 Jan 2024.